发明名称 |
Chemokine-mucin fusions linked to Glycosylphosphatidylinositol (GPI)-anchors in tissue regeneration and as tumour immune adjuvants |
摘要 |
<p>The present invention relates to chemokine-mucin fusions linked to glycosylphosphatidylinositol (GPI)-anchors and their use as anti-cancer adjuvants and as agents in tissue regeneration and suppression of vascular damage. GPI-linked chemokines are incorporated in the surface membrane of tumour cells and effect a recruitment of cytotoxic immune cells to the tumour site following injection in vivo. Leukocytes, cytotoxic T-cells and NK cells target the chemokine-GPI-anchored tumour cells and modulate cell-mediated lysis of the tumour cells. The efficiency of GPI-anchoring and modulation of immune cells can be further enhanced by linking the chemokine to a mucin domain followed by the GPI-anchor. The GPI-anchored chemokines, with or without mucin domain, are remarkably useful for the inhibition of tumour growth, tissue regeneration, and suppression of acute vascular damage to allografts.</p> |
申请公布号 |
EP1792914(A1) |
申请公布日期 |
2007.06.06 |
申请号 |
EP20050026397 |
申请日期 |
2005.12.02 |
申请人 |
LMU MUENCHEN;DKFZ DEUTSCHES KREBSFORSCHUNGSZENTRUM |
发明人 |
HUSS, RALF PROF DR;NELSON, PETER, PROF.DR;GROENE, HERMANN-JOSEF PROF.DR. |
分类号 |
C07K14/52;A61K38/19;C07K14/47;C12N15/62 |
主分类号 |
C07K14/52 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|